News

Biotech behind Eli Lilly obesity pill aims for new standard of care
The Japanese biotech behind Eli Lilly’s new blockbuster obesity pill believes it could be used with an anti-muscle wasting drug it has developed to create a new standard of patient care for weight ...
Novo Nordisk Stock (NVO) Shakes off Links Between Weight Jabs and Vision Loss
Detailed price information for Eli Lilly and Company (LLY-N) from The Globe and Mail including charting and trades.
Mounjaro manufacturer responds to dangerous 'golden dose' viral hack that can be fatal
The manufacturer of Mounjaro has responded to dangerous hack that’s been doing the rounds on social media. Videos of people ...
MarketBeat on MSN18h
With Novo Nordisk's CEO Out, Wall Street Wants an American Leader
CompanyOverview|NYSE:NVO] Despite a massively successful run as Chief Executive Officer (CEO) of pharma giant Novo Nordisk ...
Bank of America Securities Remains a Buy on Eli Lilly & Co (LLY)
Detailed price information for Eli Lilly and Company (LLY-N) from The Globe and Mail including charting and trades.
Eli Lilly is said to have posted 60% rise in obesity drug sales in India last month
Eli Lilly's (LLY) sees a 60% sales jump from April to May in India for its obesity/ diabetes drug Mounjaro. Read more here.